======= SNX5 =======
== Gene Information ==
* **Official Symbol**: SNX5
* **Official Name**: sorting nexin 5
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27131|27131]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y5X3|Q9Y5X3]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SNX5&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SNX5|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605937|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Involved in several stages of intracellular trafficking. Interacts with membranes containing phosphatidylinositol 3- phosphate (PtdIns(3P)) or phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) (PubMed:15561769). Acts in part as component of the retromer membrane-deforming SNX-BAR subcomplex. The SNX-BAR retromer mediates retrograde transport of cargo proteins from endosomes to the trans-Golgi network (TGN) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. The SNX-BAR subcomplex functions to deform the donor membrane into a tubular profile called endosome-to-TGN transport carrier (ETC) (Probable). Does not have in vitro vesicle-to-membrane remodeling activity (PubMed:23085988). Involved in retrograde transport of lysosomal enzyme receptor IGF2R (PubMed:17148574, PubMed:18596235). May function as link between endosomal transport vesicles and dynactin (Probable). Plays a role in the internalization of EGFR after EGF stimulation (Probable). Involved in EGFR endosomal sorting and degradation; the function involves PIP5K1C isoform 3 and is retromer-independent (PubMed:23602387). Together with PIP5K1C isoform 3 facilitates HGS interaction with ubiquitinated EGFR, which initiates EGFR sorting to intraluminal vesicles (ILVs) of the multivesicular body for subsequent lysosomal degradation (Probable). Involved in E-cadherin sorting and degradation; inhibits PIP5K1C isoform 3-mediated E-cadherin degradation (PubMed:24610942). Plays a role in macropinocytosis (PubMed:18854019, PubMed:21048941). {ECO:0000269|PubMed:18854019, ECO:0000269|PubMed:21048941, ECO:0000269|PubMed:24610942, ECO:0000303|PubMed:15561769, ECO:0000303|PubMed:19619496, ECO:0000303|PubMed:23085988}.
|PX|
|Vps5|
|macropinocytic cup|
|epidermal growth factor catabolic process|
|retromer, tubulation complex|
|tubular endosome|
|extrinsic component of endosome membrane|
|D1 dopamine receptor binding|
|pinocytosis|
|dynactin binding|
|positive regulation of renal sodium excretion|
|phosphatidylinositol-5-phosphate binding|
|retromer complex|
|regulation of renal sodium excretion|
|regulation of excretion|
|phagocytic cup|
|phosphatidylinositol-3,5-bisphosphate binding|
|phosphatidylinositol-4-phosphate binding|
|regulation of renal system process|
|negative regulation of blood pressure|
|negative regulation of epidermal growth factor receptor signaling pathway|
|negative regulation of ERBB signaling pathway|
|brush border|
|extrinsic component of cytoplasmic side of plasma membrane|
|regulation of epidermal growth factor receptor signaling pathway|
|phosphatidylinositol binding|
|regulation of ERBB signaling pathway|
|ruffle|
|retrograde transport, endosome to Golgi|
|cytoplasmic vesicle membrane|
|cytosolic transport|
|early endosome membrane|
|regulation of macroautophagy|
|regulation of blood pressure|
|endosomal transport|
|endosome|
|cadherin binding|
|regulation of autophagy|
|blood circulation|
|circulatory system process|
|positive regulation of secretion|
|protein heterodimerization activity|
|endocytosis|
|regulation of system process|
|cellular protein catabolic process|
|import into cell|
|protein catabolic process|
|regulation of secretion|
|regulation of cellular catabolic process|
|cellular macromolecule catabolic process|
|positive regulation of transport|
|regulation of catabolic process|
|intracellular protein transport|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|negative regulation of signal transduction|
|negative regulation of cell communication|
|negative regulation of signaling|
|protein transport|
|intracellular transport|
|peptide transport|
|amide transport|
|cellular protein localization|
|cellular macromolecule localization|
|establishment of protein localization|
|negative regulation of response to stimulus|
|positive regulation of multicellular organismal process|
|organic substance catabolic process|
|cellular catabolic process|
|establishment of localization in cell|
|nitrogen compound transport|
|regulation of transport|
|vesicle-mediated transport|
|system process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|-1.76|
|[[:results:exp302|35°C R06 exp302]]|-1.72|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 17649
* **Expression level (log2 read counts)**: 8.33
{{:chemogenomics:nalm6 dist.png?nolink |}}